as possible diagnostic and treatment
targets. Here, we discuss how claudin-related signaling pathways affect
in the expression of miRNAs)
and designing their
targeted therapy using specific miRNAs as
targets. This article
be used for diagnosis and prognosis, including the response of a particular patient to
therapyKHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) in the pathogenesis of GBM, as well as
therapies that
target these pathways. Glioblastoma remains a diffi‑
cult
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) studies in clinical laboratories. In addition, the question of the
target orientation of exosomes
Роль мутаций в гене NF1 в спорадическом канцерогенезе for
targeted therapy of both neurofibromatosis type 1 and sporadic neoplasms with mutations of this gene
processes of VTCs for effective
therapy and diagnosis. Significant progress has been made in VTC research